Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Levothyrox

Known as: Lévothyrox 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
In France, more than 2.5 million patients are currently treated with levothyroxine, mainly as the marketed product Levothyrox… Expand
  • figure 1
  • table 1
2019
2019
  • P. Nicolas
  • Clinical Pharmacokinetics
  • 2019
  • Corpus ID: 174806453
I read with interest the article published in Clinical Pharmacokinetics by Didier Concordet and colleagues [1], who reported an… Expand
Review
2019
Review
2019
In a recent ‘Current Opinion’ paper in Clinical Pharmacokinetics, Concordet et al. [1] postulated that the withinsubject variance… Expand
Review
2019
Review
2019
We are pleased to respond to the letter of Coste at al. [1] as follows. Nowhere in our article is any claim made to analyse the… Expand
2019
2019
At the request of French Regulatory Authorities, a new formulation of Levothyrox ® was licensed in France in 2017, with the… Expand
Review
2019
Review
2019
We are pleased to respond to the letter of Munafo et al. [1] as follows: in our levothyroxine article [2], we concluded that “a… Expand
Review
2018
Review
2018
Since patients may report spontaneously adverse events associated with their medications, such notifications are constantly on… Expand
2018
2018
Objectifs Le Levothyrox®, prescrit en France a plus de trois millions de patients atteints de pathologie thyroidienne, a fait l… Expand
2017
2017
Abstract Objective: Small levothyroxine (L-T4) dose changes can lead to significant clinical effects. To ensure thyroid hormone… Expand
2008
2008
A 24-year-old adult with a Down syndrome was admitted in December 2006 at the Moutiers hospital in the French Alps for an acute… Expand
  • figure 1